ST
IMMU

Spot Trading’s Immunomedics Inc IMMU Stock Holding History

Spot Trading’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,355
Closed -$51.6K – 3570
2017
Q1 		$48K Buy
+7,355
New +$37.3K ﹤0.01% 2502
2016
Q1 		– Sell
-6,878
Closed -$21K – 4208
2015
Q4 		$21K Sell
6,878
-24,940
-78% -$69.6K ﹤0.01% 3226
2015
Q3 		$55K Buy
+31,818
New +$81.2K ﹤0.01% 3263
2014
Q1 		– Sell
-6,048
Closed -$28K – 4635
2013
Q4 		$28K Buy
6,048
+4,184
+224% +$18.6K ﹤0.01% 3612
2013
Q3 		$12K Buy
1,864
+1,201
+181% +$6.91K ﹤0.01% 3848
2013
Q2 		$4K Buy
+663
New +$2.18K ﹤0.01% 4073

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Spot Trading's IMMU Position: Q2 2017 in Review

Spot Trading sold out of Immunomedics Inc (IMMU) in Q2 2017, closing a stake of 7,355 shares — an estimated $51.6K sold.

Spot Trading first reported a position in IMMU in Q2 2013 and held it in 6 quarters. The position peaked at $55K in Q3 2015. 130 funds tracked by Wall St. Rank hold IMMU as of Q2 2017.

  • Spot Trading reported no remaining Immunomedics Inc position as of Q2 2017 after selling out during the quarter.
  • Spot Trading sold 7,355 Immunomedics Inc shares in Q2 2017, an estimated $51.6K.
  • Spot Trading first reported a position in Immunomedics Inc in Q2 2013 and held it in 6 quarters.
  • Spot Trading's Immunomedics Inc position peaked at $55K in Q3 2015.
  • 130 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2017.

Based on Spot Trading's 13F filing for Q2 2017, filed 27 Jul 2017.